Scorpion and Frog Organ Lysates are Potential Source of Antitumour Activity.
Cytotoxicity
Scorpion
anticancer effects
frog
growth inhibition
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Oct 2020
01 Oct 2020
Historique:
received:
09
05
2020
entrez:
28
10
2020
pubmed:
29
10
2020
medline:
3
7
2021
Statut:
epublish
Résumé
It is noteworthy that several animal species are known to withstand high levels of radiation, and are exposed to heavy metals but rarely been reported to develop cancer. For example, the scorpion has been used as folk medicine in ancient civilizations of Iran and China, while amphibian skin is known to possess medicinal properties. Here, we elucidated the anti-tumour activity of the scorpion (Uropygi) and frog (Lithobates catesbeianus). Animals were procured and their organ lysates and sera were prepared and tested against Michigan Cancer Foundation-7 breast cancer (MCF-7), prostate cancer (PC3), Henrietta Lacks cervical cancer (HeLa), and normal human keratinocyte cells. Exoskeleton, appendages and hepatopancreas were dissected from the scorpion, whereas liver, lungs, heart, oviduct, gastrointestinal tract, gall bladder, kidneys, eggs and sera were collected from frog and organ lysates/sera were prepared. Growth inhibition assays and cytotoxicity assays were performed. Appendages, exoskeleton lysates, and hepatopancreas from scorpion exhibited potent growth inhibition, and cytotoxic effects. Furthermore, lungs, liver, gastrointestinal tract, heart, oviduct, kidneys, eggs, and sera from frog displayed growth inhibition and cytotoxic effects. Organ lysates, sera of scorpion, and amphibians possess anti-tumour activities. This is a worthy area of research as the molecular identity of the active molecule(s) together with their mechanism of action will lead to the rational development of novel anticancer agent(s).
Identifiants
pubmed: 33112561
doi: 10.31557/APJCP.2020.21.10.3011
pmc: PMC7798147
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Tissue Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3011-3018Références
Sci Rep. 2015 Jul 16;5:11988
pubmed: 26178309
Anticancer Drugs. 2008 Nov;19(10):931-9
pubmed: 18827558
J Cancer Sci Ther. 2009 Dec 1;1(2):1-4
pubmed: 20740081
Oncol Lett. 2019 Apr;17(4):3635-3640
pubmed: 30915168
Biosci Rep. 2018 Nov 9;38(6):
pubmed: 30279210
Biosci Trends. 2015 Aug;9(4):266-9
pubmed: 26355227
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Clin Ther. 2016 Jul;38(7):1551-66
pubmed: 27158009
Drug Des Devel Ther. 2020 Feb 27;14:881-893
pubmed: 32161447
Nat Rev Microbiol. 2014 Oct;12(10):661-72
pubmed: 25198138
Cancer Chemother Pharmacol. 2017 Nov;80(5):919-924
pubmed: 28795217
Toxicon. 2015 Jan;93:125-35
pubmed: 25432067
EBioMedicine. 2019 Aug;46:499-511
pubmed: 31327695
Anticancer Agents Med Chem. 2019;19(18):2251-2268
pubmed: 31660845
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Clin Exp Metastasis. 2018 Apr;35(4):309-318
pubmed: 29799080
PLoS One. 2012;7(9):e44351
pubmed: 23028527
Asian Pac J Cancer Prev. 2012;13(1):399-402
pubmed: 22502710
Toxins (Basel). 2015 Oct 08;7(10):3989-4005
pubmed: 26457717
Nature. 2019 Nov;575(7782):299-309
pubmed: 31723286
Exp Parasitol. 2017 Dec;183:194-200
pubmed: 28917711
Afr J Tradit Complement Altern Med. 2014 Aug 23;11(5):105-10
pubmed: 25395713
Biomed Res Int. 2017;2017:8201672
pubmed: 28831399
Front Neurosci. 2017 Sep 15;11:490
pubmed: 28966571
J Control Release. 2015 Dec 10;219:248-268
pubmed: 26456750
Asian Pac J Cancer Prev. 2012;13(11):5339-43
pubmed: 23317181
mBio. 2017 May 23;8(3):
pubmed: 28536285
F1000Res. 2017 Mar 17;6:288
pubmed: 28751966